Novo Nordisk: My Q1 Preview And Why I'm Doubling Down
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to seekingalpha.com, novo Nordisk Is A "Buy" Ahead Of Its Upcoming Earnings Release Novo Nordisk (NVO) is going to report its Q1 2026 results on May 6th, on Wednesday (pre-market), according to Seeking - Novo Nordisk is reiterated as a 'buy' ahead of Q1 2026 earnings, with expectations for a narrative inflection and potential upside over 40%.
Sources
1
Seeking Alpha Market News
https://seekingalpha.com/article/4897955-novo-nordisk-stock-generational-buying-opportunity-ahead-of-q1-earnings?source=feed_all_articles
2
CNBC 10000108
https://www.cnbc.com/2026/05/04/novo-nordisk-wegovy-pill-beating-eli-lilly-foundayo-early.html
3
Seeking Alpha Market News
https://seekingalpha.com/article/4898340-novo-nordisk-my-q1-preview-and-why-im-doubling-down?source=feed_all_articles